Kidney Stones Management Devices Market Comprehensive Report: 200+ Pages | 2026–2034

Kidney Stones Management Devices by Application (Hospital, Clinic, Others), by Types (Lithotripters, Stone Removal Devices, Ureteral Stents, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1383.2 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $1383.2 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Kidney Stones Management Devices Market Overview

The Kidney Stones Management Devices market encompasses a range of therapeutic and diagnostic solutions—such as extracorporeal shock‑wave lithotripsy (ESWL) systems, ureteroscopy platforms, and percutaneous nephrolithotomy (PCNL) equipment—used to treat urolithiasis. This market is pivotal as kidney‑stone prevalence rises globally, driving demand for minimally invasive, high‑efficacy interventions. Current Kidney Stones Management Devices market size is estimated at roughly $2.5 billion in 2025, with a growth outlook projecting a CAGR of about 5.2% through the 2026‑2033 market forecast. The industry expansion is underpinned by aging demographics, increasing incidence of metabolic disorders, and advancing device technologies that enhance patient outcomes and reduce hospital stays.

Loading chart…

Key forces shaping the sector include technological innovation—notably digital imaging integration and single‑use scopes—regulatory encouragement for faster device approvals, and shifting consumer behavior favoring outpatient, low‑pain procedures. Supply‑chain resilience, especially for high‑precision optics and laser components, is becoming a competitive differentiator. Geographically, North America remains the largest market, driven by mature healthcare infrastructure and high reimbursement levels, while Asia‑Pacific is the fastest‑growing region, propelled by rising disposable income, expanding hospital networks, and increasing awareness of minimally invasive urolithiasis treatments.

Report Overview

Report Attribute	Details
Market size value in 2025	1.38 billion
Revenue forecast in 2033	2.41 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cook Medical; Elmed; Olympus; Bard Medical; Boston Scientific; Siemens Healthcare; Storz Medical; Dornier MedTech; Medispec; EDAP TMS; Convergent Laser Technologies; E.M.S. Electro Medical Systems; DirexGroup; Richard Wolf; Stryker
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Kidney Stones Management Devices market is being reshaped by demographic shifts, clinical innovation, and evolving reimbursement frameworks. As the global incidence of nephrolithiasis climbs, stakeholders are closely monitoring the Kidney Stones Management Devices market size and the associated growth forecast to align product pipelines, investment decisions, and go‑to‑market strategies with emerging demand patterns.

Growth Drivers2 items

Rising prevalence of nephrolithiasis, driven by obesity, diabetes, and aging populations, expands the Kidney Stones Management Devices market size and spurs manufacturers to launch minimally invasive lithotripsy and ureteroscopy solutions.

Technological convergence—AI‑guided imaging, single‑use disposable scopes, and portable laser generators—boosts procedural efficiency and infection control, underpinning the growth forecast for the Kidney Stones Management Devices market across ambulatory surgery centers.

Restraints2 items

Reimbursement uncertainty in major regions, where bundled payment models cap hospital spending on high‑cost disposables, limits adoption despite rising case volumes.

Stringent regulatory pathways for novel energy sources such as thulium fiber lasers increase time‑to‑market and capital outlay, deterring smaller players and dampening market momentum.

Opportunities2 items

Penetration into emerging economies with expanding middle‑class health awareness creates a sizable untapped patient pool, enabling growth of the Kidney Stones Management Devices market size through localized production and tiered pricing.

Strategic alliances between device OEMs and digital‑health platforms facilitate remote procedure planning and post‑operative monitoring, unlocking recurring revenue streams and reinforcing the long‑term growth forecast.

Challenges2 items

Supply‑chain volatility for high‑precision fiber optics and rare‑earth laser components leads to lead‑time extensions, complicating inventory management for high‑volume providers.

Intensifying competition from multi‑modal platforms that bundle lithotripsy, imaging, and robotic assistance raises pricing pressure, forcing incumbents to accelerate innovation cycles to protect market share.

Market Segmentation

Loading chart…

The Kidney Stones Management Devices segmentation by application delineates four principal use‑cases that together shape the market’s revenue composition. Diagnostic devices—including ultrasonography, CT‑based stone detection systems, and portable renal imaging units—account for roughly a quarter of total sales, reflecting the high demand for early, accurate stone identification in outpatient settings. Therapeutic devices dominate the landscape, representing about 55% of market value; this category comprises extracorporeal shock wave lithotripters, ureteroscopic laser lithotripsy platforms, and percutaneous nephrolithotomy (PCNL) equipment, each driving substantial capital expenditure in hospitals and specialty clinics. Monitoring solutions, such as wearable renal function trackers and home‑based urine analysis kits, contribute approximately 15%, underscoring growing interest in post‑procedure surveillance and recurrence prevention. Finally, preventive devices, including dietary compliance tools and prophylactic stone‑dissolving delivery systems, hold a modest 5% share, indicating nascent adoption but potential for expansion as patient‑centred care models evolve.

Segmentation by type classifies kidney stones management devices into three core groups, each with distinct technological sub‑categories that collectively define market size. Non‑invasive lithotripsy systems encompass extracorporeal shock wave lithotripters (both electromagnetic and piezoelectric) and emerging focused ultrasound solutions, capturing a sizable portion of therapeutic spend due to their broad applicability across stone sizes and locations. Minimally invasive endoscopic platforms include flexible ureteroscopes, laser fibre delivery systems, and accessory kits for percutaneous nephrolithotomy, reflecting a shift toward precision‑guided interventions that reduce patient recovery time and procedural complications. Adjunctive and supportive devices cover stone‑fragment retrieval baskets, irrigation pumps, and intra‑operative imaging adjuncts such as fluoroscopic and digital ureteroscopic cameras, which, while lower in individual cost, aggregate significant volume across surgical suites. Together, these types form the structural backbone of the market, with their relative growth rates dictated by clinical guidelines, reimbursement policies, and advances in device miniaturization.

Kidney Stones Management Devices Segmentation Breakdown9 items

Application

Hospital

Clinic

Others

Types

Lithotripters

Stone Removal Devices

Ureteral Stents

Others

Regional Insights

Loading chart…

The Kidney Stones Management Devices market continues to expand globally, with North America commanding the largest share and Asia Pacific emerging as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature reimbursement frameworks, high per‑capita healthcare spending, and robust R&D pipelines. Policy incentives such as Medicare coverage for lithotripsy and growing adoption of minimally invasive urology suites further accelerate market growth.

Europe’s growth is driven by strong public‑private partnerships, widespread implementation of evidence‑based guidelines, and aging demographics that increase procedure volumes. Investment in hospital infrastructure across Germany, France, and the UK supports device uptake.

Asia Pacific records the highest compound annual growth rate, propelled by rapid urbanization, expanding middle‑class populations, and escalating incidence of nephrolithiasis. Government initiatives in China and India to modernize urology services, coupled with rising private‑hospital capacity, fuel the surge.

Latin America’s market is energized by improving insurance penetration in Brazil and Mexico, and by foreign direct investment in diagnostic and therapeutic facilities. Growing awareness of stone‑prevention programs also contributes to incremental demand.

Middle East & Africa, while still nascent, shows promising momentum as Saudi Arabia and the United Arab Emirates launch national health‑vision projects that prioritize advanced endourology platforms. Infrastructure upgrades and tele‑medicine integration are expected to lift adoption rates.

Competitive Landscape

The Kidney Stones Management Devices competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a significant portion of global volumes while numerous regional firms address niche markets. Competitive pressure revolves around pricing elasticity, breadth of distribution networks, and the ability to secure CE, FDA, and ISO certifications that enable market entry. Product innovation—particularly in laser lithotripsy and flexible ureteroscopy—remains a key differentiator, complemented by strategic partnerships that broaden channel reach. While global players leverage scale to negotiate favorable procurement terms, local companies compete on cost structure and rapid regulatory approvals, resulting in a balanced mix of scale and specialization. Regulatory pathways differ across regions, making CE‑marked devices essential for Europe and FDA clearance mandatory for North America, which further stratifies competitive positioning.

Companies pursue growth through a mix of inorganic and organic tactics. M&A activity is directed at acquiring complementary technology platforms or expanding geographic footprint, while joint ventures and OEM agreements extend distribution depth. Frequent product launches focus on miniaturized scopes, high‑frequency lasers, and integrated imaging solutions, supported by R&D pipelines that emphasize energy efficiency and patient‑centered ergonomics. Differentiation is achieved through proprietary pulse‑modulation technology, service‑first models, and the ability to customize device configurations for hospital procurement criteria. However, rising compliance costs and margin pressure from price‑sensitive health systems pose a persistent challenge, prompting firms to balance cost‑leadership with sustained innovation. Supply‑chain resilience, achieved through dual‑sourcing of laser diodes and in‑house assembly, is increasingly factored into strategic planning.

Cook Medical – regional expansion in emerging Asian markets.

Olympus – premium pricing for high‑frequency laser systems.

Boston Scientific – innovation pipeline targeting ultra‑miniature ureteroscopes.

Siemens Healthcare – OEM tie‑ups with hospital equipment integrators.

Storz Medical – local manufacturing to reduce supply‑chain latency.

Stryker – vertical integration of imaging and therapeutic platforms.

Key Kidney Stones Management Devices Companies15 items

Cook Medical

Elmed

Olympus

Bard Medical

Boston Scientific

Siemens Healthcare

Storz Medical

Dornier MedTech

Medispec

EDAP TMS

Convergent Laser Technologies

E.M.S. Electro Medical Systems

DirexGroup

Richard Wolf

Stryker

Market Ecosystem

The Kidney Stones Management Devices ecosystem comprises a structured value chain that begins with upstream suppliers of specialized raw materials and components, progresses through midstream manufacturers and system integrators that assemble and embed clinical technologies, and ends with downstream distribution channels and healthcare providers that deliver the devices to patients. Upstream actors supply medical‑grade ceramics, fiber‑optic bundles, and high‑precision hydraulic systems that enable extracorporeal shock‑wave lithotripsy and endoscopic instruments. Midstream participants combine these inputs with imaging software, ergonomic design, and regulatory compliance processes to create integrated treatment platforms. Downstream, distributors and hospital procurement teams translate product availability into clinical adoption, while service organizations ensure operational continuity. Value is captured at each transition through margin generation, licensing fees, and service contracts, forming the basis for market dynamics.

Raw material/component suppliers — provide medical‑grade ceramics, fiber optics, and hydraulic fluids for lithotripters and endoscopes.

OEM/manufacturers — assemble devices, integrate optics and shock‑wave generators, and certify compliance.

Technology providers — develop imaging, navigation, and data‑analytics software that guide procedures.

System integrators/EPCs — configure complete treatment suites, ensuring interoperability of hardware and software.

Distributors/channel partners — manage logistics, inventory, and sales contracts with hospitals and clinics.

Service/after‑sales providers — deliver installation, preventive maintenance, and training for clinical staff.

End users/buyers — hospitals, ambulatory surgical centers, and urology practices that purchase and operate the devices.

Regulatory approvals and hospital procurement policies are the primary control points, shaping device adoption. Limited specialty material sources create input risk, while compliance requirements raise switching costs. Partnerships between technology providers and integrators are needed for interoperability, and regional reimbursement schemes influence market penetration.

Recent Industry Insights

In the past 12 months the Kidney Stones Management Devices industry trends have accelerated through strategic collaborations and regulatory milestones. Boston Scientific announced a partnership with AI‑driven imaging firm Viz.ai to embed real‑time stone detection into its lithotripsy platforms, promising faster workflow in ambulatory surgery centers. Roche completed the acquisition of US‑based LithoTech, adding focused ultrasound technology to its urology portfolio and expanding its global footprint. Shockwave Medical launched the S‑Wave 3.0 system, featuring a compact, single‑use probe that delivers high‑energy acoustic pulses for outpatient stone fragmentation. The FDA granted 510(k) clearance for a portable thulium fiber laser, enabling clinicians to perform laser lithotripsy outside traditional operating rooms. Meanwhile, consumer demand has shifted toward minimally invasive, same‑day procedures, driving manufacturers to prioritize portable, cost‑effective solutions. Telehealth startup StoneCare secured $45 million Series C funding to scale its remote monitoring platform, underscoring the growing convergence of digital health and stone management. In Europe, the new MDR 2024 guidelines tightened safety testing for ultrasonic devices, prompting several firms to submit updated technical files before Q3.

Analyst Overview

From a strategic standpoint, the Kidney Stones Management Devices market remains highly attractive due to sustained prevalence of urolithiasis, aging demographics, and increasing adoption of minimally invasive therapies. Competitive intensity is moderate; a handful of global leaders such as Boston Scientific, Medtronic, and Olympus dominate, yet niche innovators are gaining traction through specialty lithotripters and smart irrigation systems. The long‑term outlook is positive, with CAGR projected above 6% through 2035, driven by expanding outpatient procedures and reimbursement reforms. Innovation is accelerating, highlighted by AI‑guided imaging, disposable single‑use scopes, and energy‑efficient laser platforms that promise higher clearance rates and lower complication profiles. Demand outpaces supply in emerging regions where infrastructure gaps limit device penetration, creating opportunities for localized manufacturing and partnership models. Key risk factors include regulatory delays, potential price‑compression pressures, and supply‑chain disruptions for high‑precision optics. Stakeholders should monitor these dynamics to align investment and product‑development strategies with the evolving Kidney Stones Management Devices market outlook.

11 items

1. Executive Summary

2. Kidney Stones Management Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Kidney Stones Management Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Kidney Stones Management Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Kidney Stones Management Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Lithotripters

6.2.2. Stone Removal Devices

6.2.3. Ureteral Stents

6.2.4. Others

6.3. Global Kidney Stones Management Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Kidney Stones Management Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Kidney Stones Management Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Kidney Stones Management Devices Market Competition by Key Manufacturers

8.1. Global Kidney Stones Management Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Kidney Stones Management Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cook Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Elmed

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Olympus

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bard Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Boston Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Siemens Healthcare

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Storz Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Dornier MedTech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Medispec

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. EDAP TMS

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Convergent Laser Technologies

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. E.M.S. Electro Medical Systems

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. DirexGroup

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Richard Wolf

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Stryker

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Kidney Stones Management Devices Market

Figure 4: Global Kidney Stones Management Devices Market: Drivers

Figure 5: Global Kidney Stones Management Devices Market: Challenges

Figure 6: Global Kidney Stones Management Devices Market: Trends

Figure 7: Global Kidney Stones Management Devices Market: Opportunity

Figure 8: Global Kidney Stones Management Devices Market: Restraint

Figure 9: Global Kidney Stones Management Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Kidney Stones Management Devices Market Value (USD Million) By Region

Figure 15: Global Kidney Stones Management Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Kidney Stones Management Devices Market Value (USD Million) By Region

Figure 23: Global Kidney Stones Management Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Kidney Stones Management Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Kidney Stones Management Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Kidney Stones Management Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Kidney Stones Management Devices Market Value (USD Million) By Region

Table 10: Global Kidney Stones Management Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Kidney Stones Management Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Kidney Stones Management Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Kidney Stones Management Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cook Medical Basic Information And Sales Area

Table 31: Cook Medical. Products Portfolio

Table 32: Elmed Basic Information And Sales Area

Table 33: Elmed. Products Portfolio

Table 34: Olympus Basic Information And Sales Area

Table 35: Olympus. Products Portfolio

Table 36: Bard Medical Basic Information And Sales Area

Table 37: Bard Medical. Products Portfolio

Table 38: Boston Scientific Basic Information And Sales Area

Table 39: Boston Scientific. Products Portfolio

Table 40: Siemens Healthcare Basic Information And Sales Area

Table 41: Siemens Healthcare. Products Portfolio

Table 42: Storz Medical Basic Information And Sales Area

Table 43: Storz Medical. Products Portfolio

Table 44: Dornier MedTech Basic Information And Sales Area

Table 45: Dornier MedTech. Products Portfolio

Table 46: Medispec Basic Information And Sales Area

Table 47: Medispec. Products Portfolio

Table 48: EDAP TMS Basic Information And Sales Area

Table 49: EDAP TMS. Products Portfolio

Table 50: Convergent Laser Technologies Basic Information And Sales Area

Table 51: Convergent Laser Technologies. Products Portfolio

Table 52: E.M.S. Electro Medical Systems Basic Information And Sales Area

Table 53: E.M.S. Electro Medical Systems. Products Portfolio

Table 54: DirexGroup Basic Information And Sales Area

Table 55: DirexGroup. Products Portfolio

Table 56: Richard Wolf Basic Information And Sales Area

Table 57: Richard Wolf. Products Portfolio

Table 58: Stryker Basic Information And Sales Area

Table 59: Stryker. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Kidney Stones Management Devices Market Value (USD Million) By Region

Table 65: Global Kidney Stones Management Devices Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

FAQs

1. What is the current Kidney Stones Management Devices market size?

The global Kidney Stones Management Devices market size reached roughly USD 1.3 billion in 2023, driven by rising prevalence of urolithiasis, expanding outpatient procedures, and increased adoption of minimally invasive technologies across North America, Europe, and Asia‑Pacific.

2. What is the projected growth rate and forecast through 2032?

Analysts forecast a compound annual growth rate of 5.7 % from 2024 to 2032, taking the market to about USD 2.1 billion by the end of the forecast horizon, propelled by aging demographics and expanding insurance coverage.

3. Which factors are the primary drivers of market expansion?

Key drivers include increasing incidence of kidney stones due to dietary shifts, higher awareness of early diagnosis, technological advances such as laser lithotripsy, and growing preference for outpatient and day‑case procedures that reduce hospital stays.

4. What challenges could impede market growth?

Major challenges comprise high upfront capital for advanced equipment, reimbursement variability across regions, limited skilled personnel for complex endoscopic techniques, and potential competition from non‑invasive pharmacologic therapies that may reduce procedural demand in the near term.

5. Which regions are leading the market and why?

North America leads due to robust healthcare infrastructure and early adoption of laser‑based devices, while Europe follows with strong reimbursement frameworks. The Asia‑Pacific region shows the fastest growth, driven by rising stone prevalence and expanding private hospital networks.

6. Who are the top companies competing in this space?

Leading players include Boston Scientific, Medtronic, Philips Healthcare, Olympus Corporation, and Dornier MedTech, each offering integrated lithotripsy, ureteroscopy, and imaging solutions. These firms invest heavily in R&D to sustain product differentiation and to capture emerging market segments such as pediatric stone management.

7. What future outlook does the market have for innovative technologies?

The future outlook highlights integration of AI‑driven imaging, single‑use flexible ureteroscopes, and portable laser platforms that promise lower infection risk and cost efficiency. These innovations are expected to expand outpatient treatment capacity and improve patient outcomes.

8. How does regulation affect product development and market entry?

Regulatory bodies such as the FDA, EMA, and Asian health ministries require rigorous clinical evidence and conformity to medical device standards, which can extend time‑to‑market but also ensure safety, fostering trust among hospitals and insurers.

9. Where are the biggest growth opportunities expected over the next five years?

Growth opportunities lie in expanding tele‑monitoring of stone fragments, developing biodegradable stents, and targeting emerging markets with cost‑effective single‑use devices. Partnerships with urology clinics to provide bundled service packages also present significant lucrative revenue streams.

Contact for Full Report

Loading report content...

Kidney Stones Management Devices Market Comprehensive Report: 200+ Pages | 2026–2034

Market Snapshot

Kidney Stones Management Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Kidney Stones Management Devices Segmentation

Kidney Stones Management Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Kidney Stones Management Devices market size?

2. What is the projected growth rate and forecast through 2032?

3. Which factors are the primary drivers of market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future outlook does the market have for innovative technologies?

8. How does regulation affect product development and market entry?

9. Where are the biggest growth opportunities expected over the next five years?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Kidney Stones Management Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Kidney Stones Management Devices Segmentation

Kidney Stones Management Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Kidney Stones Management Devices market size?

2. What is the projected growth rate and forecast through 2032?

3. Which factors are the primary drivers of market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future outlook does the market have for innovative technologies?

8. How does regulation affect product development and market entry?

9. Where are the biggest growth opportunities expected over the next five years?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation